Thumbnail

Europe Insulin Delivery Devices Market - Segmented by Type (Pens, Insulin Pumps, Insulin Syringes, Others) - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

Looking to buy the report?

Increasing Prevalence of Diabetes and Technological Advances in Delivery Systems:

Prevalence of diabetes among all ages in the European region is increasing mainly due to obesity, unhealthy diet, and physical inactivity. The incidence of autoimmune type-1 diabetes is also rising in Europe, the region has the highest number of children with type-1 diabetes. The countries in Europe, which are making the most significant contribution to the overall numbers of type-1 diabetes in children are the United Kingdom, the Russian Federation, and Germany. It has resulted in a massive demand for insulin. Germany dominates the market of insulin delivery devices. Though type-2 diabetic patient’s treatment initiated with oral drugs, insulin also required when glucose levels are not well controlled due to the unhealthy lifestyle. Thus, a demand for insulin market even exists among type-2 diabetes patients, which directly shows the impact on the insulin delivery device market. Additionally, Governments are taking initiatives to create awareness about diabetes care among people which will, in turn, result in more awareness among people and will cause an increase in diagnosed diabetes.

 With the technological advances, a better way for insulin administration discovered for the patients who need tighter control over blood sugar and hemoglobin A1c levels (HbA1C), reducing the chance of long-term complications associated with diabetes. One such advancement is the delivery of insulin through insulin pump, which prices higher than the insulin injection administration devices (Syringes and Pens) and is very sophisticated. Jet injectors are the devices, which are needle-free insulin devices. Jet-injectors uses a high-pressure jet of liquid medicament to penetrate the skin and deliver and deposit drug under the skin, without a needle.

Sky-high Price Pressure:

Many patients who use insulin syringes or insulin pens does not change the needles after every injection, which will help to reduce the economic burden of diabetes. But the fact that the patients are not realizing is that the reuse of any syringes leads to needle tip deformity and increased pain while injecting the next dosage. It can also cause skin infections. The insulin pumps and its supplies may be far more expensive than syringes used for insulin injection with several insulin pumps costing more than USD 5000; necessary supplies can cost over USD 100. Another disadvantage of insulin pump use is a higher risk of developing diabetic ketoacidosis if the pump malfunctions. Less awareness and high prices of jet injectors are also among one of the restraints faced in the insulin delivery device market.

Key Developments in the Market:

Sep 2018: SFC Fluidics develops insulin patch pump. SFC Fluidics said it obtained a USD 1.4 million grant from the National Institute of Diabetes and Digestive and Kidney Disease of the National Institutes of Health, to develop a patch pump that can deliver both insulin and glucagon in a small system.

Key Players:

NovoNordisk, Sanofi, Eli Lilly, Animas Corporation, Insulet Corporation, Medtronics, Inc., Ypsomed, Roche and Tandem Diabetes Care, and Becton Dickenson, Insujet.

Report Scope:

Attribute

Details

Base year for estimation

2017

Review Period

2012-2017

Forecast Period

2018 – 2023

Market Representation

Revenue in USD million and CAGR from 2018 – 2023

Regions covered

Europe

Report coverage

Revenue forecast and market dynamics

Reasons to Purchase this Report

  • Current and future outlook of Europe Insulin Delivery Devices market.
  • Analyzing various perspectives of the market with the help of Porter’s five forces analysis
  • The segment that is expected to dominate the market
  • Regions that are expected to witness fastest growth during the forecast period
  • Identify the latest developments and strategies employed by the major market players.
  • 3 months analyst support along with the Market Estimate sheet (in Excel).

Customization of the Report

This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.

1. Introduction

                1.1 Scope of Study

                1.2 Market Definition

                1.3 Executive Summary

2. Research Methodology

                2.1 Study Deliverables

                2.2 Study Assumptions

                2.3 Research Phases

3. Market Insights

                3.1 Technology Trends

                3.2 Industry Attractiveness - Porter's Five Forces Analysis

                                3.2.1 Bargaining Power of the Suppliers

                                3.2.2 Bargaining Power of the Consumers

                                3.2.3 Threat of New Entrants

                                3.2.4 Threat of Substitute Products and Services

                                3.2.5 Competitive Rivalry within the Industry

4.  Market Dynamics

                4.1 Drivers

                4.2 Restraints

                4.3 Opportunities

5. Market Segmentation and Analysis

                5.1 Management Device

                                5.1.1 Insulin Pump

                                                5.1.1.1 Insulin Pump Device

                                                                5.1.1.1.1 Insulin Pump Devices, Revenue (2012-2023)

                                                                5.1.1.1.2 Insulin Pump Devices, Volume (2012-2023)

                                                5.1.1.2 Insulin Pump Reservoir

                                                                5.1.1.2.1 Insulin Pump Reservoirs, Revenue (2012-2023)

                                                                5.1.1.2.2 Insulin Pump Reservoirs, Volume (2012-2023)

                                                5.1.1.3 Infusion Set

                                                                5.1.1.3.1 Infusion Sets, Revenue (2012-2023)

                                                                5.1.1.3.2 Infusion Sets, Volume (2012-2023)

                                5.1.2 Syringes

                                                5.1.2.1 Syringes, Revenue (2012-2023)

                                                5.1.2.2 Syringes, Volume (2012-2023)

                                5.1.3 Cartridges

                                                5.1.3.1 Cartridges, Revenue (2012-2023)

                                                5.1.3.2 Cartridges, Volume (2012-2023)

                                5.1.4 Disposable Pens

                                                5.1.4.1 Disposable Pens, Revenue (2012-2023)

                                                5.1.4.2 Disposable Pens, Volume (2012-2023)

                                5.1.5 Jet Injectors

                                                5.1.5.1 Jet Injectors, Revenue (2012-2023)

                                                5.1.5.2 Jet Injectors, Volume (2012-2023)

6. Market Analysis

                6.1 Europe

                                6.1.1 France

                                                6.1.1.1 France, Revenue (2012-2023)

                                                6.1.1.2 France, Volume (2012-2023)

                                6.1.2 Germany

                                                6.1.2.1 Germany, Revenue (2012-2023)

                                                6.1.2.2 Germany, Volume (2012-2023)

                                6.1.3 Italy

                                                6.1.3.1 Italy, Revenue (2012-2023)

                                                6.1.3.2 Italy, Volume (2012-2023)

                                6.1.4 Russia

                                                6.1.4.1 Russia, Revenue (2012-2023)

                                                6.1.4.2 Russia, Volume (2012-2023)

                                6.1.5 Spain

                                                6.1.5.1 Spain, Revenue (2012-2023)

                                                6.1.5.2 Spain, Volume (2012-2023)

                                6.1.6 United Kingdom (UK)

                                                6.1.6.1 UK, Revenue (2012-2023)

                                                6.1.6.2 UK, Volume (2012-2023)

                                6.1.7 Rest of Europe

                                                6.1.7.1 Rest of Europe, Revenue (2012-2023)

                                                6.1.7.2 Rest of Europe, Volume (2012-2023)

7. Competitive Landscape

                7.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements

8. Key Player Profiles

                8.1 Novo Nordisk

                8.2 Sanofi

                8.3 Eli Lilly

                8.4 Becton and Dickinson

                8.5 Medtronics

                8.6 Insulet

                8.7 Animas

                8.8 Tandem Diabetes care

                8.9 Insujet

* Each Company Profile include overview, Revenue, Product and services, SWOT, Recent Activities and strategic Analysis.

Looking to buy the report?

Need a report that reflects how COVID-19 has impacted this market and its growth?

Looking to customize report?

Email

Message

By submitting, you confirm that you agree to our privacy policy